| Co-delivery of doxorubicin and aptamer against Forkhead box M1 using chitosan-gold nanoparticles coated with nucleolin aptamer for synergistic treatment of cancer cells Z Khademi, P Lavaee, M Ramezani, M Alibolandi, K Abnous, SM Taghdisi Carbohydrate polymers 248, 116735, 2020 | 59 | 2020 |
| Multifunctional self-assembled peptide hydrogels for biomedical applications M Sedighi, N Shrestha, Z Mahmoudi, Z Khademi, A Ghasempour, ... Polymers 15 (5), 1160, 2023 | 51 | 2023 |
| A novel dual-targeting delivery system for specific delivery of CRISPR/Cas9 using hyaluronic acid, chitosan and AS1411 Z Khademi, M Ramezani, M Alibolandi, MR Zirak, Z Salmasi, K Abnous, ... Carbohydrate polymers 292, 119691, 2022 | 32 | 2022 |
| A highly sensitive fluorescent aptasensor for detection of prostate specific antigen based on the integration of a DNA structure and CRISPR-Cas12a SM Taghdisi, M Ramezani, M Alibolandi, Z Khademi, MM Hajihasani, ... Analytica Chimica Acta 1219, 340031, 2022 | 8 | 2022 |
| Dual-targeted delivery system using hollow silica nanoparticles with H+-triggered bubble generating characteristic coated with hyaluronic acid and AS1411 for … S Mirzaei, Z Khademi, R Zolfaghari, M Ramezani, M Alibolandi, K Abnous, ... Drug Development and Industrial Pharmacy 49 (10), 648-657, 2023 | 5 | 2023 |
| Calumenin knockdown, by intronic artificial microRNA, to improve expression efficiency of the recombinant human coagulation factor IX J Parnian, M Hoseindokht, Z Khademi, M Moosavi, ZS Soheili, S Samie, ... Biotechnology Letters 44 (5), 713-728, 2022 | 3 | 2022 |
| FOXM1 Aptamer-Polyethylenimine Nanoplatform Coated With Hyaluronic Acid And AS1411 Aptamer For Dual-Targeted Delivery of Doxorubicin And Synergistic Treatment of Tumor Cells Z Khademi, KS Yazdi, M Ramezani, M Alibolandi, SA Rezvani, K Abnous, ... Journal of Pharmaceutical Sciences, 2024 | 2 | 2024 |
| Cell Membrane Surface-Engineered Nanoparticles for Autoimmune Diseases and Immunotherapy Z Khademi, M Falsafi, SM Taghdisi, K Abnous Cell Membrane Surface-Engineered Nanoparticles: Biomimetic Nanomaterials for …, 2024 | 2 | 2024 |
| CRISPR/Cas9 Technology: A Novel Approach to Obesity Research Z Khademi, Z Mahmoudi, VN Sukhorukov, T Jamialahmadi, A Sahebkar Current pharmaceutical design, 2024 | 1 | 2024 |
| An update on the therapeutic role of RNAi in NAFLD/NASH H Dehghan, A Ghasempour, M Sabeti akbar-abad, Z Khademi, M Sedighi, ... Progress in Molecular Biology and Translational Science 204, 45-67, 2024 | 1 | 2024 |
| Challenges and Limitations of the Lymphatic Drug Delivery Systems Z Khademi, N Mottaghi-Dastjerdi, H Morad, N Hedayati, A Sharafi Advanced Targeting of the Lymphatic System, 453-503, 2024 | | 2024 |
| Co-delivery of doxorubicin and aptamer against Forkhead box M1 using chitosan-gold nanoparticles coated with nucleolin aptamer for synergistic treatment of cancer cells Zahra Khademi,Mohammad Ramezani, MonaAlibolandi, KhalilAbnous, Seyed ... 8th International e-congress on Nanoscience ( ICNN8), 2021 | | 2021 |
Khalil AbnousPharmaceutical Research Center, Mashhad University of Medical Sciences, Mashhad, IranVerified email at mums.ac.ir
